Evidence map›Paper›PMID 28409213›Full record

ArticleDiabetologia2017

A core outcome set for studies evaluating the effectiveness of prepregnancy care for women with pregestational diabetes.

Aoife M Egan, Sander Galjaard, Michael J A Maresh, Mary R Loeken, Angela Napoli, Eleni Anastasiou, Eoin Noctor, Harold W de Valk, Mireille van Poppel, Marie Todd and 3 more

Abstract read
In one paragraph

Article in Diabetologia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. Improving Development of Drug Treatments for Pregnant Women and the Fetus.Therapeutic innovation & regulatory science · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Aoife M EganGalway Diabetes Research Centre, Department of Medicine, National University of Ireland Galway, Galway, Ireland. aoife.egan@hse.ie.
Sander GaljaardDepartment of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, University Medical Centre Rotterdam, 's-Gravendijkwal 230, 3015 CE, Rotterdam, the Netherlands. s.galjaard@erasmusmc.nl.
Michael J A MareshDepartment of Obstetrics, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Mary R LoekenSection of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Angela NapoliDepartment of Clinical and Molecular Medicine, S. Andrea University Hospital, Sapienza, University of Rome, Rome, Italy.
Eleni AnastasiouDepartment of Endocrinology & Diabetes Center Alexandra Hospital, Athens, Greece.
Eoin NoctorDepartment of Endocrinology, University Hospital Limerick, Limerick, Ireland.
Harold W de ValkDepartment of Internal Medicine, University Medical Centre Utrecht, Utrecht, the Netherlands.
Mireille van PoppelInstitute of Sport Science, University of Graz, Graz, Austria.
Marie ToddDepartment of Medicine, Mayo University Hospital, Castlebar, Ireland.
Valerie SmithSchool of Nursing & Midwifery, Trinity College Dublin, Dublin, Ireland.
Declan DevaneSchool of Nursing & Midwifery, National University of Ireland Galway, Galway, Ireland.
Fidelma P DunneGalway Diabetes Research Centre, Department of Medicine, National University of Ireland Galway, Galway, Ireland.

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Role of Slc2a2/Glut2 in Embryo and Stem Cell Metabolism, Self-Renewal, and Pathways Involved in Diabetic EmbryopathyR01DK104649 · NIDDK · JOSLIN DIABETES CENTER · PI LOEKEN, MARY R · 2015 to 2018
$2.1M
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK104649
6 · The paper itself

Abstract

aims/hypothesisThe aim of this study was to develop a core outcome set (COS) for trials and other studies evaluating the effectiveness of prepregnancy care for women with pregestational (pre-existing) diabetes mellitus.

methodsA systematic literature review was completed to identify all outcomes reported in prior studies in this area. Key stakeholders then prioritised these outcomes using a Delphi study. The list of outcomes included in the final COS were finalised at a face-to-face consensus meeting.

resultsIn total, 17 outcomes were selected and agreed on for inclusion in the final COS. These outcomes were grouped under three domains: measures of pregnancy preparation (n = 9), neonatal outcomes (n = 6) and maternal outcomes (n = 2). CONCLUSIONS/

interpretationThis study identified a COS essential for studies evaluating prepregnancy care for women with pregestational diabetes. It is advocated that all trials and other non-randomised studies and audits in this area use this COS with the aim of improving transparency and the ability to compare and combine future studies with greater ease.

Indexed as

Preconception CareConsensusConsensus Statements as TopicDatabases, FactualDelphi TechniqueDiabetes, GestationalDiabetes MellitusFemaleHumansPregnancyPregnancy ComplicationsPregnancy in DiabeticsSurveys and QuestionnairesTreatment OutcomeClinical diabetesHealthcare deliveryOther techniquesPregnancy

Identifiers

PMID28409213
PMCPMC5487596

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.